Reports Suggest Tylenol-Autism Link, Sparking Debate and Kenvue Stock Drop
Reports from HHS and Secretary Robert F. Kennedy Jr. suggest a potential link between Tylenol use during pregnancy and autism, causing Kenvue's stock to crash despite FDA assurances.
Tylenol stock price crashes as RFK Jr. reportedly links to autism
Washington Examiner
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedHave an account? Sign in
Overview
- Upcoming reports from the US Department of Health and Human Services and Secretary Robert F. Kennedy Jr. are suggesting a potential link between Tylenol (acetaminophen) use during pregnancy and autism.
- This speculation arises amidst a rising autism incidence in the US, with 1 in 31 children diagnosed by age 8 in 2022, potentially linked to acetaminophen and folate deficiency.
- The controversy and speculation surrounding Tylenol's potential link to autism during pregnancy have reportedly caused a significant crash in the stock price of drugmaker Kenvue.
- Despite the reports, both Kenvue and Secretary Robert F. Kennedy Jr. suggest there is no causal link between Tylenol and autism, aiming to clarify the situation.
- The FDA and leading medical organizations continue to confirm acetaminophen's safety during pregnancy, emphasizing its status as one of the most studied medications in history.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources frame this story by emphasizing the established medical consensus on acetaminophen's safety and downplaying claims of an autism link. They highlight the financial impact on the Tylenol maker and quickly counter potential concerns with reassurances from medical organizations and the company itself. The narrative prioritizes the defense of the drug, presenting claims of a link as largely unsubstantiated by science and legal proceedings.
"Kenvue said in a statement: "We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.""
BBC News"Doctors and researchers have spent decades studying acetaminophen, the active ingredient in Tylenol, and have broadly found it to be the safest option for pain relief during pregnancy."
NBC NewsArticles (6)
FAQ
Recent reports, including one from Health Secretary Robert F. Kennedy Jr., suggest a potential link between prenatal Tylenol (acetaminophen) use and autism, drawing on studies indicating increased risks of neurodevelopmental disorders; however, some large studies and medical organizations have found no clear causal connection, citing possible genetic factors instead.
The FDA and leading medical organizations continue to confirm acetaminophen's safety during pregnancy and emphasize its extensive study, while groups like the American College of Obstetricians and Gynecologists state there is no clear evidence of risk from prudent use; some researchers recommend cautious, medically guided use rather than broad restrictions.
The speculation around a potential link between Tylenol use during pregnancy and autism led to a significant drop in the stock price of Kenvue, the drugmaker that produces Tylenol, despite assurances from the FDA and Kenvue that no causal link has been established.
Yes, the forthcoming report by Robert F. Kennedy Jr. is expected to identify a form of folate, folinic acid (leucovorin), as a potential way to decrease autism symptoms, though this is part of ongoing debate and research.
Large studies, including one analyzing data from over 2 million children in Sweden, found no connection between acetaminophen use during pregnancy and autism, suggesting genetic factors may play a more significant role in the disorder's development.
History
- 11d
3 articles